PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Standards Coordination Office, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.\', \'BioConsulting, Cork, Ireland.\', \'Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Canada.\', \'Biopreservation and Biobanking, Colorado Springs, Colorado, USA.\', \'Cornell Veterinary Biobank, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.\', \'Biobank Antwerp, UZA-UAntwerpen, Antwerp, Belgium.\', \'Urayasu Warakuen Clinic, Urayasu, Japan.\', \'International Agency for Research on Cancer, World Health Organization, Lyon, France.\', \'Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, Germany.\', \'Micoteca da Universidade do Minho, Centro de Engenharia Biológica, Braga, Portugal.\', \'Duke University, Durham, North Carolina, USA.\', \'CancerCare Manitoba, University of Manitoba, Winnipeg, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1089/bio.2020.0083
?:hasPublicationType
?:journal
  • Biopreservation and biobanking
is ?:pmid of
?:pmid
?:pmid
  • 33226280
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.864
?:rankingScore_hIndex
  • 26
?:title
  • Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all